These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Between responsibility and desire: Accounts of reproductive decisions from those at risk for or affected by late-onset neurological diseases. Mendes Á; Sequeiros J; Clarke AJ J Genet Couns; 2021 Oct; 30(5):1480-1490. PubMed ID: 33893685 [TBL] [Abstract][Full Text] [Related]
13. Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal. Paneque M; Félix J; Mendes Á; Lemos C; Lêdo S; Silva J; Sequeiros J Acta Med Port; 2019 Apr; 32(4):295-304. PubMed ID: 31067424 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic expression of familial amyloid polyneuropathy in Brazil. Bittencourt PL; Couto CA; Clemente C; Farias AQ; Palácios SA; Mies S; Goldberg AC Eur J Neurol; 2005 Apr; 12(4):289-93. PubMed ID: 15804246 [TBL] [Abstract][Full Text] [Related]
15. Kidney and anemia in familial amyloidosis type I. Beirão I; Lobato L; Costa PM; Fonseca I; Mendes P; Silva M; Bravo F; Cabrita A; Porto G Kidney Int; 2004 Nov; 66(5):2004-9. PubMed ID: 15496172 [TBL] [Abstract][Full Text] [Related]
16. [Newly developed drug therapies for familial amyloid polyneuropathy: diflunisal and tafamidis]. Sekijima Y Brain Nerve; 2014 Jul; 66(7):773-81. PubMed ID: 24998822 [TBL] [Abstract][Full Text] [Related]
17. Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy. Vinik EJ; Vinik AI; Paulson JF; Merkies IS; Packman J; Grogan DR; Coelho T J Peripher Nerv Syst; 2014 Jun; 19(2):104-14. PubMed ID: 24738700 [TBL] [Abstract][Full Text] [Related]
18. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture]. Harada T; Ishizaki F; Togo M; Yamashita H; Nitta K; Date Y; Nakazato M; Yamamura Y; Nakamura S No To Shinkei; 2002 Jul; 54(7):615-9. PubMed ID: 12187722 [TBL] [Abstract][Full Text] [Related]
19. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study. Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161 [TBL] [Abstract][Full Text] [Related]
20. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden. Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]